Schizophrenia Research
Volume 75, Issue 1 , Pages 83-96 , 1 June 2005

The relationships between symptom dimensions and dysphoria in schizophrenia

Received 18 November 2003 ,Revised 27 May 2004 ,Accepted 4 June 2004.

References 

  1. Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br. J. Psychiatry. 1993;163(suppl. 22):39–44
  2. Amanth J, Ghardirian AM. Drug induced mood disorder. Int. Pharmacopsychiatry. 1980;15:58–73
  3. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa; 1984;
  4. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa; 1984;
  5. Andreasen NC, Olsen S. Negative vs. positive schizophrenia. Definition and validation. Arch. Gen. Psychiatry. 1982;39:789–794
  6. Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M. Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch. Gen. Psychiatry. 1995;52:341–351
  7. Baker CA, Morrison AP. Cognitive processes in auditory hallucinations: attributional biases and metacognition. Psychol. Med. 1998;28:1199–1208
  8. Baum KM, Walker EF. Childhood behavioral precursors of adult symptom dimensions in schizophrenia. Schizophr. Res. 1995;16:111–120
  9. Bentall RP. Cognitive biases and abnormal beliefs: towards a model of persecutory delusions. In:  David AS,  Cutting J editor. The Neuropsychology of Schizophrenia. Hove, UK: Lawrence Erlbaum Associates; 1994;p. 337–360
  10. Berenbaum H, Oltmanns TF. Emotional experience and expression in schizophrenia and depression. J. Abnorm. Psychol. 1992;101:37–44
  11. Blackwood NJ, Howard RJ, Bentall RP, Murray RM. Cognitive neuropsychiatric models of persecutory delusions. Am. J. Psychiatry. 2001;158:527–539
  12. Bleulerm E. Dementia Praecox of the Group of Schizophrenias. New York: International Univ. Press; 1911;Translated by J Zinkin, Published in 1950
  13. Charlton BG. Theory of mind delusions and bizarre delusions in an evolutionary perspective: psychiatry and the social brain. In:  Brune M,  Ribbert H,  Schiefenhovel W editor. The Social Brain—Evolution and Pathology. Chichester: Wiley; 2003;
  14. Chua SE, Wright IC, Poline JB, Liddle PF, Murray RM, Frackowiak RSJ, et al. Grey matter correlates of syndromes in schizophrenia. Br. J. Psychiatry. 1997;170:406–410
  15. Ciompi L. Affect logic: an integrative model of the psyche and its relation to schizophrenia. Br. J. Psychiatry. 1994;164(suppl. 23):51–55
  16. Corcoran R, Frith CD, Mercer G. Schizophrenia, symptomatology and social inference: investigating ‘theory of mind’ in people with schizophrenia. Schizophr. Res. 1995;17:5–13
  17. Crow TJ. Positive and negative symptoms and the role of dopamine. Br. J. Psychiatry. 1985;137:383–386
  18. Cuesta MJ, Peralta V. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia. Psychiatry Res. Neuroimaging. 1995;58:227–235
  19. Cuesta MJ, Peralta V, Caro F. Premorbid personality in psychoses. Schizophr. Bull. 1999;25:801–811
  20. Davidson R. Parsing affective space: perspectives from neuropsychology and psychophysiology. Neuropsychology. 1993;7:464–475
  21. Dobson KS. The relationship between anxiety and depression. Clin. Psychol. Rev. 1985;5:307–324
  22. Drury VM, Robinson EJ, Birchwood M. ‘Theory of mind’ skills during an acute episode of psychosis and following recovery. Psychol. Med. 1998;28:1101–1112
  23. Form AF. Does old age reduce the risk of anxiety and depression? A review of epidemiological studies across the adult life span. Psychol. Med. 2000;30:11–22
  24. Freeman D, Garety P, Fowler D, Kuipers E, Dunn G, Bebbington P, et al. The London–East Anglia randomized controlled trial of cognitive-behaviour therapy for psychosis: IV. Self-esteem and persecutory delusions. Br. J. Clin. Psychol. 1998;37:415–430
  25. Galdi J. The causality of depression in schizophrenia. Br. J. Psychiatry. 1983;142:621–624
  26. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol. Med. 2001;31:189–195
  27. Guillem F, Bicu M, Bloom D, Wolf MA, Desautels R, Lalinec M, et al. Neuropsychological impairments in the syndromes of schizophrenia: a comparison between different dimensional models. Brain Cogn. 2001;46:153–159
  28. Häfner H, Hambrecht M, Löffler P, Munk-Jorgensen P, Riecher-Rössler A. Is schizophrenia a disorder of all ages? A comparison of first episodes and early course across the life-cycle. Psychol. Med. 1998;28:351–365
  29. Harris AWF, Williams L, Gordon E, Bahramali H, Slewa-Younan S. Different psychopathological models and quantified EEG in schizophrenia. Psychol. Med. 1999;29:1175–1181
  30. Henderson AS, Jorm AF, Korten AE, Jacomb PA, Christensen H, Rodgers B. Symptoms of depression and anxiety during adult life: evidence for a decline in prevalence with age. Psychol. Med. 1998;28:1321–1328
  31. Kaplan RD, Szechtman H, Franco S, Szechtman B, Nahmias C, Garnett ES, et al. Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography. Schizophr. Res. 1993;11:47–54
  32. Karel MJ. Aging and depression: vulnerability and stress across adulthood. Clin. Psychol. Rev. 1997;17:847–879
  33. Kay SR, Sevy S. Pyramidal model of schizophrenia. Schizophr. Bull. 1990;16:537–545
  34. Keefe RS, Harvey PD, Lenzenweger MF, Davidson M, Apter SH, Schmeidler J, et al. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatr. Res. 1992;44:153–165
  35. Kingdon DG, Turkington D. Cognitive Behavioral Therapy in Schizophrenia. New York: Guilford Press; 1994;
  36. Knights A, Hirsch SR. ‘Revealed’ depression and drug treatment for schizophrenia. Arch. Gen. Psychiatry. 1981;38:806–811
  37. Kraepelin E. Dementia Praecox and Paraphrenia. New York: Krieger; 1919;translated by RM Barclay, published in 1971
  38. Krasucki C, Howard R, Mann A. The relationship between anxiety disorders and age. Int. J. Geriatr. Psychiatry. 1998;13:79–99
  39. Lançon C, Auquier P, Nayt G, Reine G. Stability of the five-factor structure of the positive and negative syndrome scale (PANSS). Schizophr. Res. 2000;42:231–239
  40. Langdon R, Coltheart M. Mentalising, schizotypy and schizophrenia. Cognition. 1999;71:43–71
  41. Langdon R, Michie PT, Ward PB, McConaghy N, Catts SV, Coltheart M. Defective self and/or other mentalising in schizophrenia: a cognitive neuropsychological approach. Cogn. Neuropsychiatry. 1997;2:167–193
  42. Liddle PF. The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Br. J. Psychiatr. 1987;151:145–151
  43. Liddle PF, Morris DL. Schizophrenic symptoms and frontal lobe performance. Br. J. Psychiatr. 1991;158:340–345
  44. Liddle PF, Friston KJ, Frith CD. Patterns of cerebral blood flow in schizophrenia. Br. J. Psychiatr. 1992;160:179–186
  45. Lysaker PH, Bell MP, Bioty SM, Zito WS. The frequency of associations between positive and negative symptoms and dysphoria in schizophrenia. Compr. Psychiatry. 1995;36:113–117
  46. Lysaker PH, Bell DB, Kaplan E, Bryson G. Personality and psychosocial dysfunction in schizophrenia: the association of extraversion and neuroticism to deficits in work performance. Psychiatry Res. 1998;80:61–68
  47. Marengo J, Harrow M, Herbener ES, Sands J. A prospective longitudinal 10-year study of schizophrenia's three major factors and depression. Psychiatry Res. 2000;97:61–77
  48. Matthai R. Investigating theory of mind in schizophrenia: influence of verbalisation in disorganised and non-disorganised patients. Schizophr. Res. 1999;37:183–190
  49. McGorry PD, Bell RC, Dudgeon PL, Jackson HJ. The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychol. Med. 1998;28:935–947
  50. McIntosh AM, Forrester A, Lawrie SM, Byrne M, Harper A, Kestelman JN, et al. A factor model of the functional psychoses and the relationship of factors to clinical variables and brain morphology. Psychol. Med. 2001;31:159–171
  51. Meagher D, Quinn J, Murphy P, Kinsella A, Mullaney J, Waddington JL. Relationship of the factor structure of psychopathology in schizophrenia to the timing of initial intervention with antipsychotics. Schizophr. Res. 2001;50:95–103
  52. Mellers JDC, Sham P, Jones PB, Toone BK, Murray RM. A factor analytic study of symptoms in acute schizophrenia. Acta Psychiatr. Scand. 1996;93:92–98
  53. Mojtabai R. Duration of illness and structure of symptoms in schizophrenia. Psychol. Med. 1999;29:915–924
  54. Molina-Rodriguez V, Catalina ML, Garcia-Noblejas JA, Cuesta P. Schizophrenic syndromes and the clozapine response in treatment-resistant schizophrenia. Psychiatry Res. 1998;77:21–28
  55. Morrison AP, Haddock G, Tarrier N. Intrusive thoughts and auditory hallucinations: a cognitive approach. Behav. Cogn. Psychother. 1995;23:265–280
  56. Mueser KT, Douglas MS, Bellack AS, Morrison RL. Assessment of enduring deficit and negative symptom subtypes in schizophrenia. Schizophr. Bull. 1991;17:565–582
  57. Murphy D. Theory of mind in a sample of men with schizophrenia detained in a special hospital: its relationship to symptom profiles and neuropsychological tests. Crim. Behav. Ment. Health. 1998;8:13–26
  58. Nakaya M, Ohmori K, Komahashi T, Suwa H. Depressive symptoms in acute schizophrenic inpatients. Schizophr. Res. 1997;25:131–139
  59. Nakaya M, Suwa H, Ohmori K. Latent structures underlying schizophrenic symptoms: a five-dimensional model. Schizophr. Res. 1999;39:39–50
  60. Norman RMG, Malla AK. Dysphoric mood and symptomatology in schizophrenia. Psychol. Med. 1991;21:897–903
  61. Norman RMG, Malla AK. Correlations over time between dysphoric mood and symptomatology in schizophrenia. Compr. Psychiatry. 1994;35:34–38
  62. Norman RMG, Malla AK. A prospective study of daily stressors and symptomatology in schizophrenic patients. Soc. Psychiatry Psychiatr. Epidemiol. 1994;29:244–249
  63. Norman RMG, Davies F, Malla AK, Cortese L, Nicholson IR. Relationship of obsessive-compulsive symptomatology to anxiety, depression and schizotypy in clinical population. Br. J. Psychol. 1996;35:553–566
  64. Norman RMG, Malla AK, Morisson-Stewart SL, Helmes E, Williamson PC, Thomas J, et al. Neuropsychological correlates of syndromes in schizophrenia. Br. J. Psychiatry. 1997;170:134–139
  65. Norman RMG, Malla AK, Cortese L, Diaz F. Aspects of dysphoria and symptoms of schizophrenia. Psychol. Med. 1998;28:1433–1441
  66. Peralta V, Cuesta MJ. Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders. Schizophr. Res. 1999;38:13–26
  67. Peralta V, de Leon J, Cuesta MJ. Are there more than two syndromes in schizophrenia? A critique of the positive–negative dichotomy. Br. J. Psychiatry. 1992;161:335–343
  68. Peralta V, Cuesta MJ, de Leon J. An empirical analysis of latent structure underlying schizophrenic symptoms: a four-syndrome model. Biol. Psychiatry. 1994;36:726–736
  69. Pfohl B, Winokur G. The evolution of symptoms in institutionalized hebephrenic/catatonic schizophrenics. Br. J. Psychiatry. 1982;141:567–572
  70. Premack D, Woodruff G. Does the chimpanzee have a theory of mind?. Behav. Brain Sci. 1978;1:515–526
  71. Reine G, Bernard D, Auquier P, Le Fur B, Lançon C. Propriétés psychométriques de la version française de l'échelle de dépression de Calgary pour schizophrènes (CDSS). L'Encéphale. 2000;24:52–61
  72. Ross E. The aprosodias. Arch. Neurol. 1981;38:561–569
  73. Sarfati Y, Hardy-Baylé MC. How do people with schizophrenia explain the behaviour of others? A study of theory of mind and its relationship to thought and speech disorganization in schizophrenia. Psychol. Med. 1999;29:613–620
  74. Sarfati Y, Hardy-Baylé MC, Brunet E, Widlöcher D. Investigating theory of mind in schizophrenia: influence of verbalization in disorganized and non-disorganized patients. Schizophr. Res. 1999;25:183–190
  75. Sauer H, Hornstein C, Richter P, Mortimer A, Hirsch SR. Symptom dimensions in old-age schizophrenics. Relationship to neuropsychological and motor abnormalities. Schizophr. Res. 1999;39:31–38
  76. Sax KW, Strakowski SM, Keck PE, Upadhyaya VH, West SA, McElroy SL. Relationships among negative, positive and depressive symptoms in schizophrenia and psychotic depression. Br. J. Psychiatr. 1996;168:69–71
  77. Schultz SK, Miller DD, Oliver SE, Arndt S, Flaum M, Andreasen NC. The life course of schizophrenia: age and symptom dimensions. Schizophr. Res. 1997;23:15–23
  78. Smith DA, Mar CM, Turoff BK. The structure of schizophrenic symptoms: a meta-analytic confirmatory factor analysis. Schizophr. Res. 1998;31:57–70
  79. Spielberger CD. Anxiety and Behavior. New York: Academic Press; 1966;
  80. Spielberger CD, Gosuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory (Self-evaluation Questionnaire). Palo Alto: Consulting Psychologists Press; 1970;
  81. Stedman TL. Stedman's Medical Dictionary. 26th ed.. Baltimore: Williams and Wilkins; 1995;
  82. Strauss J, Carpenter WT, Bartko J. The diagnosis and understanding of schizophrenia: III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr. Bull. 1974;1:61–69
  83. Stuart GW, Pantelis C, Klimidis S, Minas IH. The three-syndrome model of schizophrenia: meta-analysis of an artefact. Schizophr. Res. 1999;39:233–242
  84. Taber CW. Taber's Cyclopedic Medical Dictionary. 18th ed.. Philadelphia: Davis; 1997;
  85. Toomey R, Kremen WS, Simpson JC, Samson JA, Seidman LJ, Lyons MJ, et al. Revisiting the factor structure for positive and negative symptoms: evidence from a large heterogeneous group of psychiatric patients. Am. J. Psychiatry. 1997;154:371–377
  86. Vasquez-Barquero JL, Lastra I, Nunez MJC, Castanedo SH, Dunn G. Patterns of positive and negative symptoms in first episode schizophrenia. Br. J. Psychiatry. 1996;168:693–701
  87. Watson D, Clark LA. Negative affectivity: the disposition to experience aversive emotional states. Psychol. Bull. 1984;96:465–490
  88. Wellman HM. The Child's Theory of Mind. Cambridge: MIT Press; 1990;
  89. Williams LM, Gordon E, Wright J, Bahramali H. Late component ERPs are associated with three syndromes in schizophrenia. Int. J. Neurosci. 2000;105:37–52
  90. Zubin J. Negative symptoms: are they indigenous to schizophrenia?. Schizophr. Bull. 1985;11:461–470
  91. Zubin J, Spring B. Vulnerability—new view of schizophrenia. J. Abnorm. Psychol. 1977;86:103–126

PII: S0920-9964(04)00216-6

doi: 10.1016/j.schres.2004.06.018

Schizophrenia Research
Volume 75, Issue 1 , Pages 83-96 , 1 June 2005

Article Tools

* Image Usage & Resolution